Page last updated: 2024-08-25

chitosan and meglumine

chitosan has been researched along with meglumine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Carrió, J; García, E; Miñarro, M; Pérez, P; Portus, M; Pujals, G; Suñé-Negre, JM; Tico, JR1
Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B1
Ahmadi, F; Bahrami, S; Esmaeilzadeh, S; Zarei, M1
Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M1
Mehravi, B; Mohammadi, E; Mohseni, M; Shojaei, S1
Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J1

Other Studies

6 other study(ies) available for chitosan and meglumine

ArticleYear
In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
    Parasitology research, 2008, Volume: 102, Issue:6

    Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Chitosan; Female; Inhibitory Concentration 50; Leishmania infantum; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Microspheres; Organometallic Compounds; Parasitic Sensitivity Tests

2008
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
    Immunopharmacology and immunotoxicology, 2013, Volume: 35, Issue:3

    Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing

2013
Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
    Parasitology research, 2015, Volume: 114, Issue:12

    Topics: Animals; Antiprotozoal Agents; Chitosan; Female; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome

2015
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:1

    Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties

2018
Natural polymeric nanoparticles as a non-invasive probe for mesenchymal stem cell labelling.
    Artificial cells, nanomedicine, and biotechnology, 2020, Volume: 48, Issue:1

    Topics: Alginates; Animals; Cell Tracking; Chitosan; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Meglumine; Mesenchymal Stem Cells; Mice; Nanoparticles; Organometallic Compounds; Particle Size

2020
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers

2022